Why the study?
Does age ≥80 years increase mortality and major adverse cardiac events in patients undergoing percutaneous coronary intervention compared to younger patients?
Does age ≥80 years increase mortality and major adverse cardiac events in patients undergoing percutaneous coronary intervention compared to younger patients?
Octogenarians undergoing PCI have significantly higher rates of comorbidities, mortality, and MACE compared to younger patients, highlighting the need for careful clinical evaluation prior to intervention.
Octogenarians face higher post-PCI risks; leaves open whether age-specific strategies improve outcomes in prospective cohorts.
OBJECTIVES: The objective of this study was to evaluate the clinical characteristics and outcomes of octogenarians (> or =80 years of age) in a contemporary, multi-centre percutaneous coronary intervention (PCI) registry. BACKGROUND: Octogenarians are increasingly referred for PCI. This patient population frequently has significant comorbidities, which result in major therapeutic challenges. METHODS: The study population consisted of consecutive patients undergoing PCI in seven major Australian hospitals, who were treated over a 2-year period (2004-2005). RESULTS: Of 4,360 PCI's, 11.3% (n = 491) were performed in octogenarians and 88.7% (n = 3,869) in patients <80 years. Octogenarians (compared with patients <80 years of age) were more likely female and have greater comorbidities such as cerebrovascular disease, renal impairment, congestive heart failure, and chronic airway disease. Octogenarians more frequently presented with acute coronary syndromes and cardiogenic shock. Octogenarians had significantly increased 30-day (6.0 vs. 1.4%, P < 0.01) and 12-month mortality (8.4% vs. 2.5%, P < 0.01), and major adverse cardiac event rates [(MACE), 30 days 11.3% vs. 5.4%, P < 0.01 and 12-months 18.7% vs. 12.9%, P = 0.04]. Cardiogenic shock, ST-segment elevation myocardial infarction, chronic renal failure, and age > or =80 years were independent predictors of 12-month mortality. CONCLUSIONS: Octogenarians comprise a significant cohort of patients undergoing PCI. Octogenarians have more comorbidities, and higher rates of mortality and MACE, mandating thorough clinical evaluation before acceptance for PCI.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: